Terazosin polymorph and pharmaceutical composition
US5294615A · kind A · utility
26Cited by
5References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 13, 1993 |
| Grant date | Mar 15, 1994 |
| Priority date | — |
| Expiry date | Jul 13, 2013 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A novel anhydrous crystalline polymorph of 1-(4-amino-6,7-dimethoxy- 2-quinazolinyl)-4-(2-tetrahydrofuroyl)piperazine monohydrochloride is disclosed, together with pharmaceutical formulations containing the compound. The novel polymorph exhibits a diminished food effect when administered to human subjects.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.